sciencedirect.com/science/articl… A brilliant work by my doctoral student, Girish Panigrahi, demonstrating the anticancer activity of Mitocurcumin through the novel Nrf2-Klf9-GSR axis published in FRBM today. #mitocans, #Redoxbiology @CRI_ACTREC @ACTREC_TMC
Vikram gota
@vikram_gota
Clinical pharmacologist @tmc_actrec. Like a bit of everything. Math_Travel_Netflix among fav pastimes. In awe of GenNext and their dreams. Start-up enthusiast.
43 Following 72 Followers 61 Posts
Latest posts 5
🌿 Excited to share our latest publication in Frontiers in Bioinformatics!
FloraMediX is an AI-enabled platform for recognition and therapeutic profiling of Indian medicinal plants, integrating deep learning with curated phytochemical and therapeutic knowledge.
FloraMediX is an AI-enabled platform for recognition and therapeutic profiling of Indian medicinal plants, integrating deep learning with curated phytochemical and therapeutic knowledge.
We are delighted to announce that a collaborative project between ACTREC–Tata Memorial Centre and IIT Bombay, led by Dr. Vikram Gota along with Postdoctoral Fellow Dr. Archana Kumari Redhu, and Prof. Debabrata Maiti along with PhD scholar Mr. Anirban Pal, was selected among the top 21 global innovations (from 1,175 proposals worldwide) under the WHO H2I Open Call at the WHO Global Traditional Medicine Summit 2025, New Delhi held during 17-19th December, 2025.View quoted post on X
The selected project, “TechnoHeritage Ayurveda: Data-Driven, IoT-Powered Innovations Enhancing Safety, Evidence & Sustainability in Traditional Therapies,” focuses on AI/ML-enabled scientific validation of phytochemicals, with translational potential in oral cancer and integrative oncology. The work explores how phytochemicals may modulate cancer-relevant molecular and genetic pathways, particularly those implicated in disease progression and treatment resistance. By combining traditional medical knowledge with modern data science, the project aims to generate robust, reproducible evidence aligned with global regulatory expectations and WHO frameworks.
Held in the presence of the Hon’ble Prime Minister Shri Narendra Modi and WHO Director General Dr. Tedros Adhanom Ghebreyesus, the Summit provided a global platform for this recognition, marking a proud milestone for India in evidence-driven traditional medicine innovation.
Social Impact:
This innovation addresses a major public health challenge by enabling affordable, effective, and low-toxicity treatment options for oral cancer, particularly in low- and middle-income settings. Current chemotherapeutic drugs are costly, cause severe systemic side effects, and frequently fail due to the development of drug resistance. The proposed approach integrates traditional medicinal knowledge with advanced AI-driven discovery to identify bioactives that can be used either as standalone therapeutic options or in synergy with existing chemotherapies to enhance efficacy and overcome resistance. This strategy can reduce treatment failure while maintaining or improving quality of life, preserving essential functions such as speech and swallowing, and lowering financial burden. At a societal level, it strengthens sustainable healthcare systems, supports responsible use of traditional knowledge, and empowers communities through ethical benefit-sharing, advancing inclusive, human-centered cancer care.
#AIML #Ayurveda #TraditionalMedicine #WHOH2I #MinistryOfAyush #DrugDiscovery #CancerResearch #HealthInnovation #IITBombay #ACTREC #TMC #MinistryOfAyush #WHO #EvidenceBasedMedicine #PMO #HealthcareInnovation
Ministry of Education, Government of India, New Delhi
Mitochondrial targeting for resistant cancers is real. Our recent work on mitochondrial targeting using Mitocurcumin and the mechanism of cell death has been elucidated in our recent article. @CRI_ACTREC @ACTREC_TMC @GirishPanigrah5
Please take a look! link.springer.com/10.1007/s00210…
Please take a look! link.springer.com/10.1007/s00210…
Impressive work! Congratulations
Really glad to have this work identifying the key role of PV-neurons in the ventral hippocampus in gating the anxiolytic actions of the serotonergic psychedelic, DOI, out in @NeuroCellPress @TIFRScience sciencedirect.com/science/articl…View quoted post on X